Literature DB >> 15330899

Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.

Naohiko Koide1, Akihito Nishio, Toshiyuki Sato, Atsushi Sugiyama, Shin-ichi Miyagawa.   

Abstract

OBJECTIVES: Macrophage chemoattractant protein-1 (MCP-1) is a chemokine-inducing infiltration of macrophages, which can play several roles in tumor growth and metastasis. We have attempted to clarify the relationship between MCP-1 expression and macrophage infiltration in esophageal squamous cell carcinoma (SCC).
METHODS: Paraffin-embedded sections of tissue samples taken from 56 patients with esophageal SCC after curative surgery were immunohistochemically stained for MCP-1, CC chemokine receptor 2 (CCR-2), and thymidine phosphorylase (TP). Macrophage recruitment in SCC was evaluated by monocytic count based on CD68 immunostaining. Microvessels immunostained for Factor VIII-related antigen were counted in SCC, and microvessel density (MVD) was determined. Ki-67 labeling index was calculated based on Ki-67 immunostaining, and an apoptotic index was calculated based on the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate biotin nick end labeling.
RESULTS: MCP-1 was expressed in cancer cells of 31 SCC (55.4%) and in stromal cells mainly identified as macrophages of 16 SCC (28.6%). CCR-2 was expressed in stromal cells of all SCC and in vascular endothelial cells of 15 SCC (26.8%). There was a significant correlation between the expression of MCP-1 in cancer cells and of CCR-2 in stromal cells. TP was expressed in stromal cells in 76.7% of the SCC. Monocytic count, MVD, and Ki-67 LI in SCC with MCP-1 expression in cancer cells were higher than that without, and apoptotic index in SCC with MCP-1 expression in cancer cells were lower than that without. Furthermore, the monocytic count was positively correlated with MVD, while it was inversely correlated with apoptotic index. Clinicopathologically, MCP-1 expression in cancer cells was correlated with venous invasion, distant metastasis, and lymph node metastasis. Monocytic count in SCC with venous invasion, distant metastasis, or lymph node metastasis was higher than that without them. Five-year survival rate in the patients with high monocytic count or MCP-1 expression was worse than that with a low monocytic count or without MCP-1 expression.
CONCLUSIONS: These results suggest that MCP-1 expression and macrophage infiltration is associated with angiogenic promotion in esophageal SCC. MCP-1 expression may be interactively associated with macrophage infiltration in esophageal SCC; MCP-1 may play an important role in tumor angiogenesis through production of angiogenic factors, such as TP, by recruited macrophages in esophageal SCC. Furthermore, CCR-2 expression in vascular endothelial cells may participate partially in angiogenesis. Clinicopathologically, esophageal SCC patients with MCP-1 expression have no favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15330899     DOI: 10.1111/j.1572-0241.2004.30733.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  62 in total

1.  Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.

Authors:  Yanping Ding; Nan Song; Yongzhang Luo
Journal:  Cancer Microenviron       Date:  2012-04-20

2.  Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients.

Authors:  Yan-Hong Ni; Liang Ding; Xiao-Feng Huang; Ying-chun Dong; Qin-Gang Hu; Ya-Yi Hou
Journal:  Tumour Biol       Date:  2015-02-11

3.  Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.

Authors:  Hong Wang; Qiongwen Zhang; Hongyu Kong; Yunhui Zeng; Meiqin Hao; Ting Yu; Jing Peng; Zhao Xu; Jingquan Chen; Huashan Shi
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Variations in stromal signatures in breast and colorectal cancer metastases.

Authors:  Jonathan A Webster; Andrew H Beck; Mimansa Sharma; Inigo Espinosa; Britta Weigelt; Marthe Schreuder; Kelli D Montgomery; Kristin C Jensen; Matt van de Rijn; Robert West
Journal:  J Pathol       Date:  2010-10       Impact factor: 7.996

5.  Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.

Authors:  Melanie Mestdagt; Myriam Polette; Giovanna Buttice; Agnes Noël; Atsuhisa Ueda; Jean-Michel Foidart; Christine Gilles
Journal:  Int J Cancer       Date:  2006-01-01       Impact factor: 7.396

6.  Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.

Authors:  Karen M Bussard; David J Venzon; Andrea M Mastro
Journal:  J Cell Biochem       Date:  2010-12-01       Impact factor: 4.429

7.  Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.

Authors:  Xiao-Hua Zeng; Zhou-Luo Ou; Ke-Da Yu; Lan-Yun Feng; Wen-Jing Yin; Jing Li; Zhen-Zhou Shen; Zhi-Min Shao
Journal:  Med Oncol       Date:  2014-08-06       Impact factor: 3.064

8.  Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes.

Authors:  Aroonwan Lam-ubol; Dustin Hopkin; Elena M Letuchy; Zoya B Kurago
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

9.  Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.

Authors:  Inigo Espinosa; Andrew H Beck; Cheng-Han Lee; Shirley Zhu; Kelli D Montgomery; Robert J Marinelli; Kristen N Ganjoo; Torsten O Nielsen; C Blake Gilks; Robert B West; Matt van de Rijn
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

10.  Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness.

Authors:  Hisashi Takeuchi; Michio Tanaka; Ayako Tanaka; Akisa Tsunemi; Hidenobu Yamamoto
Journal:  Oncol Lett       Date:  2016-03-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.